Acute Leukemia in a Patient with Sickle-Cell Anemia Treated with Hydroxyurea
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Letters5 December 2000Acute Leukemia in a Patient with Sickle-Cell Anemia Treated with HydroxyureaScott Wilson, MDScott Wilson, MDEl Rio Health Center; Tucson, AZ 85745 (Wilson)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-133-11-200012050-00029 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Sickle-cell disease is rarely associated with hematogenous malignancy. Hydroxyurea can reduce the frequency of painful crises in sickle-cell disease; its leukemogenic potential is uncertain. We report a case of acute myelogenous leukemia in a patient with sickle-cell disease treated with hydroxyurea.In May 1999, a 42-year-old woman with sickle-cell anemia was admitted with recurrent pain. She had been treated with hydroxyurea since April 1993. In April 1998, hemoglobin electrophoresis demonstrated a hemoglobin A2 level of 0.017, a fetal hemoglobin level of 0.38, and a hemoglobin S level of 0.60. On admission, the hematocrit was 0.17, the mean ...References1. Najean Y, Rain JD. Treatment of polycythemia vera: use of 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age. The French Polycythemia Study Group. Blood. 1997;89:2319-27. CrossrefMedlineGoogle Scholar2. Sterkers Y, Preudhomme C, Lai JL, Demory JL, Caulier MT, Wattel E, et al . Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood. 1998;91:616-22. CrossrefMedlineGoogle Scholar3. Rauch A, Borromeo M, Ghafoor A, Khoyratty B, Maheshwari J. Leukemogenesis of hydroxyurea in the treatment of sickle cell anemia [Abstract]. Blood. 1999;94 Suppl 1 415a. Google Scholar4. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al . Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332:1317-22. CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: El Rio Health Center; Tucson, AZ 85745 (Wilson) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByMyeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literatureOccurrence of acute myeloid leukemia in hydroxyurea-treated sickle cell disease patientComorbidities in aging patients with sickle cell diseaseAccelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell diseaseIncreased risk of leukemia among sickle cell disease patients in CaliforniaHydroxycarbamide treatment in sickle cell disease: estimates of possible leukaemia risk and of hospitalization survival benefitDevelopment of Myelodysplastic Syndrome and Acute Myeloid Leukemia 15 Years after Hydroxyurea Use in a patient with sickle Cell AnemiaCurrent strategies for the management of children with sickle cell diseaseHodgkin lymphoma in a sickle cell anaemia child treated with hydroxyureaThe pharmacotherapy of sickle cell diseasePharmacotherapy of essential thrombocythemiaSystematic Review: Hydroxyurea for the Treatment of Adults with Sickle Cell DiseaseSophie Lanzkron, MD, John J. Strouse, MD, Renee Wilson, MSc, Mary Catherine Beach, MD, MPH, Carlton Haywood, MA, HaeSong Park, MD, MPH, Catherine Witkop, MD, MPH, Eric B. Bass, MD, MPH, and Jodi B. Segal, MD, MPHTraitement des patients drépanocytaires par hydroxyurée : efficacité et toléranceDNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyureaDecreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermediaModern treatment of thalassaemia intermediaParents' Assessment of Risk in Sickle Cell Disease Treatment With HydroxyureaNew Therapies for Sickle Cell DiseaseHydroxyurea therapy for sickle cell disease in community-based practices: A survey of Florida and North Carolina hematologists/oncologistsder(8)t(1;8) in myeloblastic transformation of ET with hydroxyurea as the sole prior treatmentA critical review of anagrelide therapy in essential thrombocythemia and related disordersMalignancy in patients with sickle cell diseaseMalignancies in sickle cell disease patients treated with hydroxyureaAcute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphanThe role of hydroxyurea in the management of sickle cell diseasePathophysiological-Based Approaches to Treatment of Sickle Cell DiseaseThe role of hydroxyurea in sickle cell diseaseHydroxyurea treatment of sickle cell anemia in hospital-based practicesDeve
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Cited by
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Systematic Review: Hydroxyurea for the Treatment of Adults with Sickle Cell Disease
Lanzkron, S., Strouse, J. J., Wilson, R., Beach, M. C., Haywood, C., Park, H., Witkop, C., Bass, E. B., & Segal, J. B. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-12-200806170-00221 · Cited by 287
Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality: Is It Time to Intervene?
Coller, B. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000156877.94472.a5 · Cited by 286
Increased risk of leukemia among sickle cell disease patients in California
Brunson, A., Keegan, T. H. M., Bang, H., Mahajan, A., Paulukonis, S., & Wun, T. (2017) · Blood · doi:10.1182/blood-2017-05-783233 · Cited by 139
Li, Y., Maule, J., Neff, J. L., McCall, C. M., Rapisardo, S., Lagoo, A. S., Yang, L.-H., Crawford, R. D., Zhao, Y., & Wang, E. (2019) · Modern Pathology · doi:10.1038/s41379-019-0325-6 · Cited by 39
Metadata
- Authors
- Wilson, S.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2000-12-05
- Volume
- 133
- Issue
- 11
- Pages
- 925-926
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2048963709
- Cited by
- 48
- References
- 1
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute Leukemia in a Patient with Sickle-Cell Anemia Treated with Hydroxyurea. https://app.cochat.ai/papers/10.7326/0003-4819-133-11-200012050-00029
- The paper
- Wilson, S. (2000). Acute Leukemia in a Patient with Sickle-Cell Anemia Treated with Hydroxyurea. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-133-11-200012050-00029
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.